CTOR

Citius Oncology, Inc. Common Stock

11 hedge funds and large institutions have $230K invested in Citius Oncology, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
+4
Holders Change %
+57.14%
% of All Funds
0.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
2
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
HF
1
HRT Financial
New York
$78K +$78K +68,543 New
UBS Group
2
UBS Group
Switzerland
$28.5K +$26.6K +23,173 +1,420%
Citadel Advisors
3
Citadel Advisors
Florida
$26.1K +$26.1K +22,699 New
IA
4
IFP Advisors
Florida
$25.5K +$16.2K +14,080 +173%
XT
5
XTX Topco
Cayman Islands
$24.3K +$24.3K +21,095 New
Geode Capital Management
6
Geode Capital Management
Massachusetts
$14.5K +$14.5K +12,651 New
YCM
7
Yakira Capital Management
Connecticut
$13.8K -$4.03K -3,500 -23%
Renaissance Technologies
8
Renaissance Technologies
New York
$12.9K +$12.9K +11,196 New
Osaic Holdings
9
Osaic Holdings
Arizona
$6.3K
Bank of America
10
Bank of America
North Carolina
$184
TRCT
11
Tower Research Capital (TRC)
New York
$47
VF
12
Virtu Financial
New York
-$14K -10,291 Closed